Zhitong Finance App News, Lukang Pharmaceutical (600789.SH) issued an announcement. Recently, Shandong Lukang Pharmaceutical Group Saite Co., Ltd., a holding subsidiary of the company, received a “Drug Registration Certificate” issued by the State Drug Administration for sacubatrol valsartan sodium tablets. The drug is a generic drug approved in 4 categories according to the new registration classification, and is considered to have passed the consistent evaluation of generic drug quality and efficacy. This drug is used to treat chronic heart failure and essential hypertension with reduced ejection fraction.

Disclaimer:Webull uses external vendor Google Translation Service for news translations where we endeavour to ensure these are correct, however, we recommend that you please double-check this information accordingly. Webull is not responsible for translation errors or issues.